Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Situ Thrombolysis With tPA and Inflow Lung Perfusion Analysis in Patient With Severe Covid-19 Infection

NCT04926428 is registered in ClinicalTrials.gov with Grupo Mexicano para el Estudio de la Medicina Intensiva as lead sponsor.

NCT NCT04926428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04926428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Situ Thrombolysis With tPA and Inflow Lung Perfusion Analysis in Patient With Severe Covid-19 Infection
Lead sponsor
Grupo Mexicano para el Estudio de la Medicina Intensiva
Phase
Not applicable
Overall status
Completed
Start date
December 25, 2020
Completion date
March 30, 2021
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19